Clinical Trials Browser

Phase 2 × Advanced Non-small Cell Lung Cancer × pembrolizumab × Clear all

NCT04699123 2025-05-13

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Active not recruiting

Advanced Non-small Cell Lung Cancer